Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Operating Leases (2019 - 2025)

Apyx Medical (APYX) has disclosed Operating Leases for 7 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 0.56% year-over-year to $4.5 million, compared with a TTM value of $4.5 million through Dec 2025, down 0.56%, and an annual FY2025 reading of $4.5 million, down 0.56% over the prior year.
  • Operating Leases was $4.5 million for Q4 2025 at Apyx Medical, up from $4.2 million in the prior quarter.
  • Across five years, Operating Leases topped out at $5.4 million in Q2 2023 and bottomed at $30000.0 in Q3 2021.
  • Average Operating Leases over 5 years is $3.0 million, with a median of $4.3 million recorded in 2025.
  • The sharpest move saw Operating Leases crashed 80.39% in 2021, then surged 1413.33% in 2022.
  • Year by year, Operating Leases stood at $30000.0 in 2021, then surged by 1466.67% to $470000.0 in 2022, then surged by 941.7% to $4.9 million in 2023, then decreased by 8.44% to $4.5 million in 2024, then dropped by 0.56% to $4.5 million in 2025.
  • Business Quant data shows Operating Leases for APYX at $4.5 million in Q4 2025, $4.2 million in Q3 2025, and $4.3 million in Q2 2025.